Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1918106

Cover Image

PUBLISHER: Knowledge Sourcing Intelligence | PRODUCT CODE: 1918106

Echocardiography Market - Forecast from 2026 to 2031

PUBLISHED:
PAGES: 149 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3950
PDF (Multiple User License)
USD 4550
PDF (Enterprise License)
USD 6950

Add to Cart

The echocardiography market is forecasted to rise at a 6.67% CAGR, reaching USD 3.444 billion in 2031 from USD 2.337 billion in 2025.

The echocardiography market is positioned for steady growth, underpinned by its critical role as a non-invasive diagnostic modality for cardiovascular assessment. This medical procedure utilizes high-frequency ultrasound waves to generate real-time images of the heart's structure and function, providing vital information without the risks associated with invasive techniques. The market's expansion is driven by a convergence of demographic trends, technological innovation, and the clinical advantages of ultrasound-based cardiac imaging.

A primary catalyst for market growth is the escalating global prevalence of cardiovascular diseases. The increasing burden of heart and circulatory ailments, compounded by sedentary lifestyles and an aging global population, creates a sustained demand for effective diagnostic tools. This demographic shift is particularly significant as elderly populations are more susceptible to cardiac conditions, thereby amplifying the need for accessible and reliable diagnostic imaging such as echocardiography.

The intrinsic advantages of echocardiographic devices over alternative cardiac diagnostic methods represent a significant market driver. Unlike invasive procedures like cardiac catheterization, which carry risks of complications and require extended hospital stays, echocardiography is non-invasive, safer, and typically more cost-effective. Its established position in the cardiovascular diagnostic workflow, often following initial assessments like electrocardiography, ensures its continued and widespread use in clinical practice.

Technological advancement is a powerful force propelling the market forward. Continuous innovation in imaging capabilities is enhancing the utility and application of echocardiography. The development and adoption of advanced techniques, including 4D intracardiac echo (ICE), are expanding its use into complex areas such as guiding electrophysiology procedures. These technological improvements offer greater precision and can potentially reduce the need for general anesthesia in certain interventions, thereby improving patient outcomes and expanding the procedure's applicability.

Within the market, the transthoracic echocardiography (TTE) test segment is anticipated to hold a significant revenue share. As the most commonly prescribed form of echocardiography, TTE offers comprehensive details on cardiac structure and function, aiding in diagnosis and guiding treatment decisions. Its advantages-including ease of use, real-time information delivery, noninvasive nature, and relatively low cost-make it particularly valuable in intensive care units and standard clinical settings, securing its dominant position.

Geographically, North America is expected to exhibit significant growth. This is attributed to the region's high prevalence of cardiac diseases, a well-developed and technologically advanced healthcare infrastructure, and a strong emphasis on patient care. The growing elderly population in the region, which is disproportionately affected by cardiovascular problems, further fuels the demand for minimally invasive diagnostic procedures like intracardiac echocardiography.

The competitive landscape is characterized by a focus on product innovation and strategic development. Manufacturers are increasingly concentrating on creating portable, compact, and transportable ECG and echo devices to cater to mobile healthcare practitioners and enable rapid diagnosis in diverse settings. A key industry trend involves enhancing interoperability with electronic medical record (EMR) and cardiovascular information systems (CVIS) to streamline workflow. Furthermore, companies are actively developing wearable and mobile monitoring equipment, reflecting a strategic move towards decentralized and continuous cardiac monitoring, which is anticipated to unlock new growth opportunities and strengthen market competitiveness.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Echocardiography Market Segmentation:

  • By Type
  • Transthoracic Echocardiography
  • Transesophageal Echocardiography
  • Stress Echocardiography
  • By Technology
  • 2D Echocardiography
  • 3D Echocardiography
  • Others
  • By End-User
  • Hospitals
  • Diagnostic Centers
  • Others
  • By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others
Product Code: KSI061615576

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. ECHOCARDIOGRAPHY MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Transthoracic Echocardiography
  • 5.3. Transesophageal Echocardiography
  • 5.4. Stress Echocardiography

6. ECHOCARDIOGRAPHY MARKET BY TECHNOLOGY

  • 6.1. Introduction
  • 6.2. 2D Echocardiography
  • 6.3. 3D Echocardiography
  • 6.4. Others

7. ECHOCARDIOGRAPHY MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Diagnostic Centers
  • 7.4. Others

8. ECHOCARDIOGRAPHY MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Spain
    • 8.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Fujifilm Holdings Corporation
  • 10.2. Koninklijke Philips N.V.
  • 10.3. ULTRA ICE PLUS(TM) Ultrasound Imaging Catheter
  • 10.4. Canon Inc.
  • 10.5. ESAOTE SPA
  • 10.6. CHISON Medical Technologies Co., Ltd
  • 10.7. Samsung Healthcare (Samsung Electronics Co. Ltd)
  • 10.8. Siemens Healthineers (Siemens)
  • 10.9. GE Healthcare
  • 10.10. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key Benefits for the Stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!